What is it?
Synthetic melanocortin analog
Peptide Library · checked July 31, 2026
Melanotan II
Melanotan II can darken skin. That visible effect is real; it is not proof of safety or FDA approval. FDA describes Melanotan II as an unapproved drug and flags product-quality, immune-reaction, and serious-adverse-event concerns.
TL;DR
The lowdown
Four answers first. The source record follows.
What do humans show?
Pigmentation can occur through melanocortin-receptor activity. That visible response does not establish long-term safety, cancer protection, product purity, or an acceptable benefit-risk profile.
Where does FDA stand?
None
What is known—and not?
The central uncertainty is not merely a list of possible side effects. It is the combination of an unapproved drug, incomplete clinical characterization, uncertain product identity, and serious published safety signals.
U.S. status · July 31, 2026
Approval, compounding, product, sport.
- FDA approval
- Not FDA-approved; FDA records describe it as an unapproved new drug
- U.S. federal record
- Not FDA-approved; FDA records describe it as an unapproved new drug
- Product identity
- Online products are not FDA-approved tanning medicines
- Sport
- Not specifically named in WADA's 2026 List. Class and approval-status rules still apply, so absence by name is not clearance; athletes should verify the exact product with an anti-doping organization.
This reports the dated federal and sport record. It does not determine whether a particular product or transaction complies with state or federal law, and it is not legal advice.
01
What it is
Melanotan II is a synthetic peptide promoted online as an injectable or nasal tanning product. FDA enforcement records have long described it as an unapproved new drug. An online disclaimer or “research use” label does not convert a product marketed for human tanning into an approved medicine.
02
Risks and warning limits
The central uncertainty is not merely a list of possible side effects. It is the combination of an unapproved drug, incomplete clinical characterization, uncertain product identity, and serious published safety signals.
PepCurrent does not provide dosing, sourcing, product-authentication, or tanning advice.
03
What humans actually show
- Pigmentation can occur through melanocortin-receptor activity. That visible response does not establish long-term safety, cancer protection, product purity, or an acceptable benefit-risk profile.
- FDA's compounding-risk page says published case reports discuss serious events including melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome, and priapism. Case reports do not establish incidence or prove causation, but they are safety signals—not evidence of harmlessness.
- FDA also flags aggregation, peptide-related impurities, and potential immunogenicity for certain compounded routes.
04
FDA and U.S. status
Melanotan II is not an FDA-approved tanning drug. FDA records describe enforcement involving its marketing and sale as an unapproved injectable tanning agent, including claims that extended beyond tanning.
Melanotan II is not FDA approved, and this announcement does not change that status. FDA has separately announced that its Pharmacy Compounding Advisory Committee (PCAC) will meet before the end of February 2027 to consider whether to add Melanotan II to a federal list of bulk substances that may be eligible for certain traditional pharmacy compounding (the 503A Bulks List). FDA has not yet posted the exact meeting date, time, location, or materials. Advisory recommendations are non-binding. The announcement is not a vote, recommendation, final list action, drug approval, ban, or product-specific safety conclusion.
05
What would change this answer
- FDA enforcement and import alerts
- The announced FDA advisory meeting: exact date, materials, voting questions, any committee recommendation, and any later final FDA action
- New human safety data with clearly identified products
- Reports involving pigmented lesions, neurologic events, or priapism
- Social claims that equate tanning response with protection from ultraviolet injury
06
Sources and records
What changed
Added the source-verified Claim Check to the structured claim/source/change registry.
What would change our answer
A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.
Version history · 1 entry
- v1 · 2026-07-16Initial structured record created from the reviewed Claim Check.Source ↗
Educational journalism only; not medical advice. We do not evaluate individual products or link vendors.
Boundary: PepCurrent explains public evidence and regulatory records. We do not evaluate individual products, recommend use, name vendors, or provide protocols.